Travere Therapeutics, Inc.

TVTXNASDAQHealthcareBiotechnology

$49.60- (-)1Y +93.23%

As of Oct 16, 2026 close

Market cap: $4.93B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $22.59$68.73
Volume (live): -
Avg. volume (3M): 1.80M

Travere Therapeutics, Inc. (TVTX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Travere Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy

Based on 8 unique analysts

Medium Confidence∞:1 Buy/Sell

Average Price Target

$72.63

+46.43% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest TVTX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 2, 2026	Joseph Pantginis	HC Wainwright	Reiterates	Buy	$67.00
Sep 24, 2026	Vamil Divan	Guggenheim	Reiterates	Buy	$75.00 → $89.00 +14.00 (+18.7%)
Sep 24, 2026	Jason Zemansky	BofA Securities	Maintains	Buy	$71.00
Sep 22, 2026	Laura Chico	Wedbush	Maintains	Buy	$75.00 → $76.00 +1.00 (+1.3%)
Aug 17, 2026	Allison Bratzel	Piper Sandler	Maintains	Buy	$49.00 → $68.00 +19.00 (+38.8%)
Aug 12, 2026	Edward Nash	Canaccord Genuity	Maintains	Buy	$70.00
Aug 10, 2026	Gavin Clark-Gartner	Evercore ISI Group	Maintains	Buy	$68.00 → $78.00 +10.00 (+14.7%)
Aug 9, 2026	Alex Thompson CFA	Stifel Nicolaus	Maintains	Hold	$43.00 → $62.00 +19.00 (+44.2%)

Joseph Pantginis

HC Wainwright

BuyReiterates

$67.00

Oct 2

Vamil Divan

Guggenheim

BuyReiterates

$75.00 → $89.00

Sep 24

Jason Zemansky

BofA Securities

BuyMaintains

$71.00

Sep 24

Laura Chico

Wedbush

BuyMaintains

$75.00 → $76.00

Sep 22

Allison Bratzel

Piper Sandler

BuyMaintains

$49.00 → $68.00

Aug 17

Edward Nash

Canaccord Genuity

BuyMaintains

$70.00

Aug 12

Gavin Clark-Gartner

Evercore ISI Group

BuyMaintains

$68.00 → $78.00

Aug 10

Alex Thompson CFA

Stifel Nicolaus

HoldMaintains

$43.00 → $62.00

Aug 9

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 2, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for TVTX?

The analyst consensus rating for TVTX is Buy, based on the latest ratings from 8 analysts over the last 90 days.

What is the average price target for TVTX?

The average 12-month price target for TVTX is $72.63, representing an upside of 46.4% from the Oct 16, 2026 close of $49.60.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.